1 |
Other: |
- |
- |
- |
- |
002 [2] 2 , 65 💬 |
2 |
Other: 0 mg |
- |
- |
- |
- |
097 [1] 97 💬 |
3 |
Other: 0.02% fm, sh, tbcl |
- |
- |
- |
- |
053 [1] 53 💬 |
4 |
Other: 0.9% sodium chloride |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
065 [1] 65 💬 |
5 |
Other: 0.9ml sodium chloride |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
271 [1] 271 💬 |
6 |
Other: 1 food elimination diet |
- |
- |
- |
- |
098 [1] 98 💬 |
7 |
Other: 1 food elimination diet therapy |
- |
- |
- |
- |
098 [1] 98 💬 |
8 |
Other: 100% pomegranate juice |
Pomegranate |
- |
- |
- |
096 [2] 96, 97 💬 |
9 |
Other: 13c6 leucine |
Leucine |
[1] D00030 D00030 💬 |
- |
- |
005 [3] 5 , 7 , 127 💬 |
10 |
Other: 18f-fdg |
Fludeoxyglucose (18F) |
- |
- |
- |
046 [2] 46, 84 💬 |
11 |
Other: 18f-fdg pet/ct |
Fludeoxyglucose (18F) |
- |
- |
- |
041 [1] 41 💬 |
12 |
Other: 18f-fluorodeoxyglucose (18f-fdg) pet/ct |
Fludeoxyglucose (18F) |
- |
- |
- |
084 [1] 84 💬 |
13 |
Other: 18f-ge-180 |
Flutriciclamide F-18 |
- |
- |
- |
046 [1] 46 💬 |
14 |
Other: 2h standardized aerobic exercise |
- |
- |
- |
- |
078 [1] 78 💬 |
15 |
Other: 31-phosphorus rmn spectroscopy |
Phosphorus |
- |
- |
- |
008 [1] 8 💬 |
16 |
Other: 4 food elimination diet |
- |
- |
- |
- |
098 [1] 98 💬 |
17 |
Other: 4 food elimination diet (post 1fed failure) |
- |
- |
- |
- |
098 [1] 98 💬 |
18 |
Other: 5-asa withdrawal |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
096 [1] 96 💬 |
19 |
Other: 6 food elimination diet (after 1fed failure) |
- |
- |
- |
- |
098 [1] 98 💬 |
20 |
Other: 6 food elimination diet therapy |
- |
- |
- |
- |
098 [1] 98 💬 |
21 |
Other: 60% oxygen |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
085 [1] 85 💬 |
22 |
Other: [11c]-methionine pet/mri |
Methionine |
[2] D00019 D00019, D04983 D04983 💬 |
- |
- |
075 [1] 75 💬 |
23 |
Other: [11c]donepezil pet |
Donepezil |
[2] D00670 D00670, D07869 D07869 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
006 [1] 6 💬 |
24 |
Other: a-step |
- |
- |
- |
- |
299 [1] 299 💬 |
25 |
Other: a-step (new protocol) |
- |
- |
- |
- |
299 [1] 299 💬 |
26 |
Other: abdominal compression |
- |
- |
- |
- |
017 [1] 17 💬 |
27 |
Other: absorptive clearance scan |
- |
- |
- |
- |
299 [1] 299 💬 |
28 |
Other: acute response to high-impact exercise |
- |
- |
- |
- |
096 [1] 96 💬 |
29 |
Other: ad libitum water intake |
Water |
[1] D00001 D00001 💬 |
- |
- |
067 [1] 67 💬 |
30 |
Other: adalimumab |
Adalimumab |
[1] D02597 D02597 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
31 |
Other: adalimumab treatment |
Adalimumab |
[1] D02597 D02597 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
151 [1] 151 💬 |
32 |
Other: additional therapies |
- |
- |
- |
- |
097 [1] 97 💬 |
33 |
Other: air - oxygen |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
299 [1] 299 💬 |
34 |
Other: amyotrophic lateral sclerosis functional rating scale-revised |
- |
- |
- |
- |
002 [1] 2 💬 |
35 |
Other: antigen (wheat base soy sauce) spray |
Wheat |
[1] D06902 D06902 💬 |
- |
- |
098 [1] 98 💬 |
36 |
Other: anxiety |
- |
- |
- |
- |
013 [1] 13 💬 |
37 |
Other: assessment of medication compliance |
- |
- |
- |
- |
098 [1] 98 💬 |
38 |
Other: autogenic drainage |
- |
- |
- |
- |
299 [1] 299 💬 |
39 |
Other: autologous platelet rich plasma |
- |
- |
- |
- |
035 [1] 35 💬 |
40 |
Other: autologous serum and rebamipide 2% |
Rebamipide |
[1] D01121 D01121 💬 |
- |
- |
053 [1] 53 💬 |
41 |
Other: avise pg - diagnostic test |
- |
- |
- |
- |
046 [1] 46 💬 |
42 |
Other: balance |
Isoxaflutole |
- |
- |
- |
006 [3] 6 , 13, 299 💬 |
43 |
Other: balance exercise |
Isoxaflutole |
- |
- |
- |
006 [1] 6 💬 |
44 |
Other: balance exercises |
Isoxaflutole |
- |
- |
- |
013 [1] 13 💬 |
45 |
Other: balance trainer balance exercises |
Isoxaflutole |
- |
- |
- |
013 [1] 13 💬 |
46 |
Other: balance training |
Isoxaflutole |
- |
- |
- |
006 [2] 6 , 13 💬 |
47 |
Other: baseline serum vitamin d level at or above 50 nmol/l |
Vitamin D |
- |
- |
- |
046 [1] 46 💬 |
48 |
Other: baseline serum vitamin d level below 50 nmol/l |
Vitamin D |
- |
- |
- |
046 [1] 46 💬 |
49 |
Other: beetroot juice extract |
- |
- |
- |
- |
113 [1] 113 💬 |
50 |
Other: berg balance scale |
Isoxaflutole |
- |
- |
- |
006 [2] 6 , 13 💬 |
51 |
Other: best medical treatment |
- |
- |
- |
- |
006 [1] 6 💬 |
52 |
Other: best practice |
- |
- |
- |
- |
060 [1] 60 💬 |
53 |
Other: biological samples |
- |
- |
- |
- |
206 [1] 206 💬 |
54 |
Other: biopsy |
- |
- |
- |
- |
051 [1] 51 💬 |
55 |
Other: blood collection for measurement of eculizumab peak concentrations |
Eculizumab |
[1] D03940 D03940 💬 |
C5 [1] C5 💬 |
Complement and coagulation cascades [9] Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
062 [1] 62 💬 |
56 |
Other: blood drawing only group c |
- |
- |
- |
- |
049 [1] 49 💬 |
57 |
Other: blood glucose results |
Dextrose, unspecified form |
- |
- |
- |
299 [1] 299 💬 |
58 |
Other: blood sample |
- |
- |
- |
- |
299 [1] 299 💬 |
59 |
Other: blood sample and cotton skin swabs |
Cotton |
- |
- |
- |
162 [1] 162 💬 |
60 |
Other: blood samples |
- |
- |
- |
- |
093 [1] 93 💬 |
61 |
Other: blood sampling for laboratory developed test (ldt) analysis |
- |
- |
- |
- |
065 [1] 65 💬 |
62 |
Other: blood test |
- |
- |
- |
- |
096 [1] 96 💬 |
63 |
Other: blood-flow restricted training |
- |
- |
- |
- |
015 [1] 15 💬 |
64 |
Other: bmi greater than or equal to 30kg/m2 scheduled for psg. undergo blood draw (arterial blood gas and metabolic panel) and data collection from psg study. |
- |
- |
- |
- |
230 [1] 230 💬 |
65 |
Other: bmi greater than or equal to 30kg/m2 scheduled for psg. undergo blood draw (venous blood gas and metabolic panel) and data collection from psg study. |
- |
- |
- |
- |
230 [1] 230 💬 |
66 |
Other: bone marrow cell transplantation |
- |
- |
- |
- |
274 [1] 274 💬 |
67 |
Other: brain mri (magnetic resonance imaging) |
- |
- |
- |
- |
017 [1] 17 💬 |
68 |
Other: brief pain inventory questionnaire |
- |
- |
- |
- |
019 [1] 19 💬 |
69 |
Other: bronchoalveolar samples |
- |
- |
- |
- |
051 [1] 51 💬 |
70 |
Other: caffeine |
Caffeine |
[2] D00528 D00528, D01453 D01453 💬 |
ADORA1 [11] ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism [22] Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 [1] 13 💬 |
71 |
Other: calcium stable isotope |
Calcium |
- |
- |
- |
186 [1] 186 💬 |
72 |
Other: carbon monoxide-bubbled mediums |
Activated charcoal |
[2] D03251 D03251, D09706 D09706 💬 |
- |
- |
298 [1] 298 💬 |
73 |
Other: carboxy methyl cellulose |
Methylcellulose |
[2] D00093 D00093, D04996 D04996 💬 |
- |
- |
053 [1] 53 💬 |
74 |
Other: cardiopulmonary evaluation |
- |
- |
- |
- |
013 [1] 13 💬 |
75 |
Other: cawthorne cooksey exercises |
- |
- |
- |
- |
013 [1] 13 💬 |
76 |
Other: cd lfd |
- |
- |
- |
- |
096 [1] 96 💬 |
77 |
Other: cd-treat diet |
- |
- |
- |
- |
096 [1] 96 💬 |
78 |
Other: challenge agent: capsaicin |
Capsaicin |
[1] D00250 D00250 💬 |
TRPV1 [1] TRPV1 💬 |
Inflammatory mediator regulation of TRP channels [2] Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
019 [1] 19 💬 |
79 |
Other: classic, progressive endurance training |
- |
- |
- |
- |
013 [1] 13 💬 |
80 |
Other: coa-z |
- |
- |
- |
- |
120 [1] 120 💬 |
81 |
Other: coaching sessions |
- |
- |
- |
- |
049 [1] 49 💬 |
82 |
Other: coduse balance training and step square exercises |
Isoxaflutole |
- |
- |
- |
013 [1] 13 💬 |
83 |
Other: coffee |
- |
- |
- |
- |
096 [1] 96 💬 |
84 |
Other: cognitive training |
- |
- |
- |
- |
206 [1] 206 💬 |
85 |
Other: colchicine cessation |
Colchicine |
[1] D00570 D00570 💬 |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease [10] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
266 [1] 266 💬 |
86 |
Other: collection of csf, blood, urine, saliva |
- |
- |
- |
- |
006 [1] 6 💬 |
87 |
Other: communicative effectiveness survey |
- |
- |
- |
- |
002 [1] 2 💬 |
88 |
Other: comparator: cpet cycle ergometer (gold standard) |
Gold |
- |
- |
- |
299 [1] 299 💬 |
89 |
Other: computer game based balance and walking rehabilitation for individuals with parkinson's disease |
Isoxaflutole |
- |
- |
- |
006 [1] 6 💬 |
90 |
Other: concomitant medication |
- |
- |
- |
- |
049 [1] 49 💬 |
91 |
Other: continuation of dornase alfa (dnase) |
Dornase alfa |
[1] D03896 D03896 💬 |
- |
- |
299 [1] 299 💬 |
92 |
Other: continuation of hypertonic saline (hs) |
- |
- |
- |
- |
299 [1] 299 💬 |
93 |
Other: continue their usual therapy |
- |
- |
- |
- |
066 [1] 66 💬 |
94 |
Other: control |
- |
- |
- |
- |
006 [8] 6 , 19, 70, 75, 85, 97, 162, 193 💬 |
95 |
Other: control diet |
- |
- |
- |
- |
096 [1] 96 💬 |
96 |
Other: control group |
- |
- |
- |
- |
002 [1] 2 💬 |
97 |
Other: control group(normal saline) |
- |
- |
- |
- |
097 [1] 97 💬 |
98 |
Other: control wound treatment |
- |
- |
- |
- |
036 [1] 36 💬 |
99 |
Other: controlled environment tests (series of tasks of everyday life) |
- |
- |
- |
- |
006 [1] 6 💬 |
100 |
Other: controls primary cervical dystonia (trihexyphenidyl) |
Trihexyphenidyl |
[2] D00787 D00787, D08638 D08638 💬 |
CHRM1 [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
006 [1] 6 💬 |
101 |
Other: conventional balance training |
Isoxaflutole |
- |
- |
- |
013 [1] 13 💬 |
102 |
Other: conventional drugs |
- |
- |
- |
- |
097 [1] 97 💬 |
103 |
Other: conventional pca mode |
- |
- |
- |
- |
070 [1] 70 💬 |
104 |
Other: core stability |
- |
- |
- |
- |
013 [1] 13 💬 |
105 |
Other: corn starch |
Starch, corn |
[1] D05297 D05297 💬 |
- |
- |
049 [1] 49 💬 |
106 |
Other: corticotropin releasing hormone (crh) |
Corticotropin |
[1] D00146 D00146 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
078 [1] 78 💬 |
107 |
Other: cough monitor |
Methamidophos |
- |
- |
- |
085 [1] 85 💬 |
108 |
Other: crohn's disease treatment-with-eating diet (cd-treat diet) |
- |
- |
- |
- |
096 [1] 96 💬 |
109 |
Other: crohns disease exclusion diet |
- |
- |
- |
- |
096 [1] 96 💬 |
110 |
Other: cultured thymus tissue implantation and parental parathyroid transplantation |
- |
- |
- |
- |
065 [1] 65 💬 |
111 |
Other: cultured thymus tissue implantation with parathyroid transplantation |
- |
- |
- |
- |
065 [1] 65 💬 |
112 |
Other: current treatment |
- |
- |
- |
- |
046 [1] 46 💬 |
113 |
Other: cyclosporin a |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
060 [1] 60 💬 |
114 |
Other: cysteamine bitartrate |
Cysteamine |
[2] D03634 D03634, D03635 D03635 💬 |
- |
- |
019 [1] 19 💬 |
115 |
Other: d-xylose |
Xylose |
[1] D06346 D06346 💬 |
- |
- |
098 [1] 98 💬 |
116 |
Other: d5w |
- |
- |
- |
- |
222 [1] 222 💬 |
117 |
Other: data capture |
Bifenthrin |
- |
- |
- |
006 [1] 6 💬 |
118 |
Other: dead sea solar and water treatment |
Water |
[1] D00001 D00001 💬 |
- |
- |
046 [1] 46 💬 |
119 |
Other: determination of calcium intake by a dietician interview |
Calcium |
- |
- |
- |
013 [2] 13, 46 💬 |
120 |
Other: dextrose water 5% |
Dextrose, unspecified form |
[1] D00001 D00001 💬 |
- |
- |
056 [1] 56 💬 |
121 |
Other: diagnostic laboratory biomarker analysis |
- |
- |
- |
- |
074 [1] 74 💬 |
122 |
Other: diagnostics for glucose tolerance with 3 different methods. |
Dextrose, unspecified form |
- |
- |
- |
299 [1] 299 💬 |
123 |
Other: diary completion |
- |
- |
- |
- |
006 [1] 6 💬 |
124 |
Other: diet |
- |
- |
- |
- |
240 [1] 240 💬 |
125 |
Other: diet treatment |
- |
- |
- |
- |
240 [1] 240 💬 |
126 |
Other: diet-cd |
- |
- |
- |
- |
096 [1] 96 💬 |
127 |
Other: dietary intervention with no-carrageenan diet |
- |
- |
- |
- |
097 [1] 97 💬 |
128 |
Other: discontinuation of dornase alfa (dnase) |
Dornase alfa |
[1] D03896 D03896 💬 |
- |
- |
299 [1] 299 💬 |
129 |
Other: discontinuation of hypertonic saline (hs) |
- |
- |
- |
- |
299 [1] 299 💬 |
130 |
Other: dmt withdrawal |
- |
- |
- |
- |
013 [1] 13 💬 |
131 |
Other: dobutamine |
Dobutamine |
[4] D00632 D00632, D03879 D03879, D03880 D03880, D03881 D03881 💬 |
ADRB1 [1] ADRB1 💬 |
Adrenergic signaling in cardiomyocytes [10] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
215 [1] 215 💬 |
132 |
Other: donor derived g-csf mobilized pbc |
Filgrastim |
[1] D03235 D03235 💬 |
CSF3R [1] CSF3R 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
060 [1] 60 💬 |
133 |
Other: donor lymphocyte infusion |
- |
- |
- |
- |
065 [1] 65 💬 |
134 |
Other: dose reduction to 2mg/l |
- |
- |
- |
- |
046 [1] 46 💬 |
135 |
Other: dose reduction to 5mg/l |
- |
- |
- |
- |
046 [1] 46 💬 |
136 |
Other: drug free |
- |
- |
- |
- |
049 [1] 49 💬 |
137 |
Other: dual task performance |
- |
- |
- |
- |
013 [1] 13 💬 |
138 |
Other: dummy tripterygium wilfordii hook f (twhf) |
Tripterygium wilfordii whole |
- |
- |
- |
046 [1] 46 💬 |
139 |
Other: dynamic balance training |
Isoxaflutole |
- |
- |
- |
013 [1] 13 💬 |
140 |
Other: dystrophin levels |
- |
- |
- |
- |
113 [1] 113 💬 |
141 |
Other: dyt 1 dystonia |
- |
- |
- |
- |
006 [1] 6 💬 |
142 |
Other: dyt 1 dystonia (healthy control) |
- |
- |
- |
- |
006 [1] 6 💬 |
143 |
Other: e-monitoring |
- |
- |
- |
- |
097 [1] 97 💬 |
144 |
Other: eating assessment tool 10 |
- |
- |
- |
- |
002 [1] 2 💬 |
145 |
Other: eating assessment tool-10 |
- |
- |
- |
- |
002 [1] 2 💬 |
146 |
Other: echocardiogram |
- |
- |
- |
- |
113 [1] 113 💬 |
147 |
Other: eculizumab |
Eculizumab |
[1] D03940 D03940 💬 |
C5 [1] C5 💬 |
Complement and coagulation cascades [9] Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
109 [1] 109 💬 |
148 |
Other: eit |
- |
- |
- |
- |
228 [1] 228 💬 |
149 |
Other: electroencephalogram (eeg) awake andextended overnight |
- |
- |
- |
- |
019 [1] 19 💬 |
150 |
Other: elimination diet |
- |
- |
- |
- |
098 [1] 98 💬 |
151 |
Other: empiric use of calcium carbonate and calcitriol |
Calcitriol |
[3] D00129 D00129, D00932 D00932, D10802 D10802 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
235 [1] 235 💬 |
152 |
Other: endurance |
- |
- |
- |
- |
006 [1] 6 💬 |
153 |
Other: enteral nutrition |
- |
- |
- |
- |
096 [1] 96 💬 |
154 |
Other: epiduroscopy |
- |
- |
- |
- |
070 [1] 70 💬 |
155 |
Other: epistaxis charts |
- |
- |
- |
- |
227 [1] 227 💬 |
156 |
Other: eus procedure |
- |
- |
- |
- |
298 [1] 298 💬 |
157 |
Other: evaluation by investigator |
- |
- |
- |
- |
006 [1] 6 💬 |
158 |
Other: evaluation of degree chronic fatigue. |
- |
- |
- |
- |
013 [1] 13 💬 |
159 |
Other: event-related evoked potential using electroencephalography (eeg). |
- |
- |
- |
- |
006 [1] 6 💬 |
160 |
Other: exclusion diet |
- |
- |
- |
- |
096 [1] 96 💬 |
161 |
Other: exclusive enteral nutrition |
- |
- |
- |
- |
096 [1] 96 💬 |
162 |
Other: exclusive enteral nutrition (een) |
- |
- |
- |
- |
096 [1] 96 💬 |
163 |
Other: exercise capacity |
- |
- |
- |
- |
299 [1] 299 💬 |
164 |
Other: exercise echocardiography |
- |
- |
- |
- |
058 [1] 58 💬 |
165 |
Other: exercise followed cold water immersion |
Water |
[1] D00001 D00001 💬 |
- |
- |
046 [1] 46 💬 |
166 |
Other: exercise intervention |
- |
- |
- |
- |
013 [2] 13, 18 💬 |
167 |
Other: faecal bacterial transplantation |
- |
- |
- |
- |
097 [1] 97 💬 |
168 |
Other: fast mimicking diet |
- |
- |
- |
- |
097 [1] 97 💬 |
169 |
Other: fatigue |
- |
- |
- |
- |
013 [1] 13 💬 |
170 |
Other: fear of falling |
- |
- |
- |
- |
013 [1] 13 💬 |
171 |
Other: fingolimod |
Fingolimod |
[1] D10001 D10001 💬 |
S1PR1 [1] S1PR1 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 [1] 13 💬 |
172 |
Other: fitbit activity monitor |
Methamidophos |
- |
- |
- |
049 [1] 49 💬 |
173 |
Other: flow cytometry |
- |
- |
- |
- |
028 [3] 28, 51, 60 💬 |
174 |
Other: fluid restriction |
- |
- |
- |
- |
072 [1] 72 💬 |
175 |
Other: fluorescein angiography |
Fluorescein |
[2] D01261 D01261, D02024 D02024 💬 |
- |
- |
019 [1] 19 💬 |
176 |
Other: fog |
- |
- |
- |
- |
006 [1] 6 💬 |
177 |
Other: food diary |
- |
- |
- |
- |
065 [1] 65 💬 |
178 |
Other: four square step test |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
179 |
Other: fractional exhaled no (feno) |
- |
- |
- |
- |
096 [1] 96 💬 |
180 |
Other: fresh frozen plasma |
- |
- |
- |
- |
014 [1] 14 💬 |
181 |
Other: fruit juice |
- |
- |
- |
- |
299 [1] 299 💬 |
182 |
Other: functional involvement of identified epigenetic alterations |
- |
- |
- |
- |
102 [1] 102 💬 |
183 |
Other: functional mobility |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
184 |
Other: functional oral intake scale |
- |
- |
- |
- |
002 [1] 2 💬 |
185 |
Other: functional reach test |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
186 |
Other: gadobutrol |
Gadobutrol |
[1] D07420 D07420 💬 |
- |
- |
046 [1] 46 💬 |
187 |
Other: gait and balance group training |
Isoxaflutole |
- |
- |
- |
006 [1] 6 💬 |
188 |
Other: general and neurological examination |
- |
- |
- |
- |
019 [1] 19 💬 |
189 |
Other: general population |
- |
- |
- |
- |
046 [2] 46, 271 💬 |
190 |
Other: generation of induced pluripotent stem cells (ipsc) from fibroblasts obtained by skin biopsy |
- |
- |
- |
- |
102 [1] 102 💬 |
191 |
Other: gh pause |
- |
- |
- |
- |
078 [1] 78 💬 |
192 |
Other: ghrh plus arginine test |
Arginine |
[2] D02982 D02982, D08523 D08523 💬 |
GHRHR [1] GHRHR 💬 |
Growth hormone synthesis, secretion and action [2] Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction |
078 [1] 78 💬 |
193 |
Other: ghrh+arg, ghrh+arg, itt |
Somatorelin |
[1] D08523 D08523 💬 |
GHRHR [1] GHRHR 💬 |
Growth hormone synthesis, secretion and action [2] Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction |
078 [1] 78 💬 |
194 |
Other: glucose |
Dextrose, unspecified form |
- |
- |
- |
254 [1] 254 💬 |
195 |
Other: glucose -potentiated arginine (gpa) stimulation tests |
Arginine |
[1] D02982 D02982 💬 |
- |
- |
299 [1] 299 💬 |
196 |
Other: glucose profile for 2 weeks |
Dextrose, unspecified form |
- |
- |
- |
299 [1] 299 💬 |
197 |
Other: glucose solution at a dose of 1.75 g/kg (up to a maximum of 75 g) for the ogtt and glucose solution at a dose of 0.5 g/kg (up to a maximum of 35 g) was injected in 2.5-3 min for the igtt |
Dextrose, unspecified form |
- |
- |
- |
299 [1] 299 💬 |
198 |
Other: glycerine gel |
Glycerin |
[1] D00028 D00028 💬 |
- |
- |
265 [1] 265 💬 |
199 |
Other: green tea (camellia sinensis) |
Green tea leaf |
[1] D06903 D06903 💬 |
- |
- |
096 [1] 96 💬 |
200 |
Other: group 2 (dmards treated group) |
- |
- |
- |
- |
046 [1] 46 💬 |
201 |
Other: group b sle one blood donation |
- |
- |
- |
- |
049 [1] 49 💬 |
202 |
Other: group balance training |
Isoxaflutole |
- |
- |
- |
013 [1] 13 💬 |
203 |
Other: group exercise: community setting |
- |
- |
- |
- |
070 [1] 70 💬 |
204 |
Other: growth hormone |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [1] 78 💬 |
205 |
Other: gsk2586184 single dose taken with food |
- |
- |
- |
- |
049 [1] 49 💬 |
206 |
Other: gsk2586184 single dose taken without food |
- |
- |
- |
- |
049 [1] 49 💬 |
207 |
Other: haematopoietic stem cell transplantation (hsct) |
- |
- |
- |
- |
065 [1] 65 💬 |
208 |
Other: hand training |
- |
- |
- |
- |
046 [1] 46 💬 |
209 |
Other: harkány medicinal water |
Water |
[1] D00001 D00001 💬 |
- |
- |
046 [1] 46 💬 |
210 |
Other: healthy controls |
- |
- |
- |
- |
063 [1] 63 💬 |
211 |
Other: healthy volunteers |
- |
- |
- |
- |
046 [1] 46 💬 |
212 |
Other: hemicellulose crystalline |
- |
- |
- |
- |
006 [1] 6 💬 |
213 |
Other: hepatic elastography |
- |
- |
- |
- |
299 [1] 299 💬 |
214 |
Other: high energy / protein diet. |
- |
- |
- |
- |
096 [1] 96 💬 |
215 |
Other: high glycemic index meal |
- |
- |
- |
- |
299 [1] 299 💬 |
216 |
Other: high intensity exercise and balance training |
Isoxaflutole |
- |
- |
- |
006 [1] 6 💬 |
217 |
Other: high performance liquid chromatography |
- |
- |
- |
- |
096 [1] 96 💬 |
218 |
Other: high resolution peripheral quantitative computed tomography (hrpqct) |
- |
- |
- |
- |
172 [1] 172 💬 |
219 |
Other: high water intake |
Water |
[1] D00001 D00001 💬 |
- |
- |
067 [1] 67 💬 |
220 |
Other: high-impact exercise intervention |
- |
- |
- |
- |
096 [1] 96 💬 |
221 |
Other: histamine |
Histamine |
[1] D08040 D08040 💬 |
HRH1 [4] HRH1, HRH2, HRH3, HRH4 💬 |
Calcium signaling pathway [4] Calcium signaling pathway, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 [1] 13 💬 |
222 |
Other: histone acetylation profiles of cells of srt patients with crebbp mutations |
- |
- |
- |
- |
102 [1] 102 💬 |
223 |
Other: historical control |
- |
- |
- |
- |
002 [1] 2 💬 |
224 |
Other: hoehn and yahr scale |
- |
- |
- |
- |
006 [1] 6 💬 |
225 |
Other: honey |
Honey |
[1] D06776 D06776 💬 |
- |
- |
098 [1] 98 💬 |
226 |
Other: human milk derived fortifier |
Cow milk |
- |
- |
- |
210 [1] 210 💬 |
227 |
Other: human umbilical cord-derived mscs and cyclosporin a |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
060 [1] 60 💬 |
228 |
Other: human/bovine milk |
Cow milk |
- |
- |
- |
210 [1] 210 💬 |
229 |
Other: hydrocortisone |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
075 [1] 75 💬 |
230 |
Other: hydrogen peroxide |
Hydrogen |
[1] D00008 D00008 💬 |
- |
- |
013 [1] 13 💬 |
231 |
Other: hydroxychloroquine/chloroquine |
Chloroquine |
[4] D02125 D02125, D02366 D02366, D03469 D03469, D08050 D08050 💬 |
- |
- |
046 [1] 46 💬 |
232 |
Other: hyperbaric oxygen |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
096 [1] 96 💬 |
233 |
Other: hyperbaric oxygen therapy |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
097 [2] 97, 226 💬 |
234 |
Other: hyperpolarized xenon mri |
Xenon |
[2] D01901 D01901, D06339 D06339 💬 |
- |
- |
299 [1] 299 💬 |
235 |
Other: hypoglycemic clamp |
- |
- |
- |
- |
299 [1] 299 💬 |
236 |
Other: ibuprofen and isosorbide dinitrate combination |
Ibuprofen |
[6] D00126 D00126, D00347 D00347, D00516 D00516, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
113 [1] 113 💬 |
237 |
Other: iloprost (ventavis inhaled, bayq6256) |
Iloprost |
[1] D02721 D02721 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
238 |
Other: imaging |
- |
- |
- |
- |
013 [1] 13 💬 |
239 |
Other: imitation surgical procedure (isp) |
- |
- |
- |
- |
006 [1] 6 💬 |
240 |
Other: immunologic technique |
- |
- |
- |
- |
049 [1] 49 💬 |
241 |
Other: impact of biotherapy on postoperative morbidity in ulcerative colitis |
- |
- |
- |
- |
097 [1] 97 💬 |
242 |
Other: impact peptide 1.5 |
- |
- |
- |
- |
299 [1] 299 💬 |
243 |
Other: inactive drug |
- |
- |
- |
- |
226 [1] 226 💬 |
244 |
Other: incontinence severity |
- |
- |
- |
- |
013 [1] 13 💬 |
245 |
Other: individualized exercises: clinical setting |
- |
- |
- |
- |
070 [1] 70 💬 |
246 |
Other: induced hypotonic hyponatremia - siad model |
- |
- |
- |
- |
072 [1] 72 💬 |
247 |
Other: infliximab (ifx) infusion |
Infliximab |
[1] D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
248 |
Other: inhalable hypertonic saline 7% |
- |
- |
- |
- |
299 [1] 299 💬 |
249 |
Other: inhalable hypertonic saline 7% + hyaluronan 0.1% |
Hyaluronic acid |
[1] D08043 D08043 💬 |
- |
- |
299 [1] 299 💬 |
250 |
Other: inhaled hyperpolarized xenon-129 |
Xenon |
[2] D01901 D01901, D06339 D06339 💬 |
- |
- |
228 [1] 228 💬 |
251 |
Other: intensify treatment with the existing drug |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
252 |
Other: intensive supportive care |
- |
- |
- |
- |
066 [1] 66 💬 |
253 |
Other: intrathecal saline injection |
- |
- |
- |
- |
013 [1] 13 💬 |
254 |
Other: isa 51 |
- |
- |
- |
- |
050 [1] 50 💬 |
255 |
Other: isa 51 vg |
- |
- |
- |
- |
049 [1] 49 💬 |
256 |
Other: itt, itt, ghrh+arg. |
Somatorelin |
[1] D08523 D08523 💬 |
GHRHR [1] GHRHR 💬 |
Growth hormone synthesis, secretion and action [2] Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction |
078 [1] 78 💬 |
257 |
Other: iv saline infusion |
- |
- |
- |
- |
096 [1] 96 💬 |
258 |
Other: iv steroids combination alone |
- |
- |
- |
- |
041 [1] 41 💬 |
259 |
Other: ivig |
Human immunoglobulin G |
- |
- |
- |
035 [1] 35 💬 |
260 |
Other: joint mobilizations (spine, sacroiliac, hip) |
- |
- |
- |
- |
070 [1] 70 💬 |
261 |
Other: ketogenic diet |
- |
- |
- |
- |
019 [1] 19 💬 |
262 |
Other: lab work |
- |
- |
- |
- |
046 [1] 46 💬 |
263 |
Other: laboratory biomarker analysis |
- |
- |
- |
- |
011 [21] 11, 13, 14, 16, 26, 28, 34, 49, 51, 60, 62, 65, 89, 96, 97, 232, 283, 284, 285, 298, 331 💬 |
264 |
Other: language intervention |
- |
- |
- |
- |
206 [1] 206 💬 |
265 |
Other: lengthening adalimumab dosing interval |
Adalimumab |
[1] D02597 D02597 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
266 |
Other: leukapheresis- collection of stem cells |
- |
- |
- |
- |
096 [1] 96 💬 |
267 |
Other: levothyroxine |
Levothyroxine |
[2] D01010 D01010, D08125 D08125 💬 |
THRA [2] THRA, THRB 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway |
078 [1] 78 💬 |
268 |
Other: liberation therapy |
- |
- |
- |
- |
013 [1] 13 💬 |
269 |
Other: liquid meal test (carbohydrate-rich) |
- |
- |
- |
- |
299 [1] 299 💬 |
270 |
Other: liquid meal test (fat-rich) |
- |
- |
- |
- |
299 [1] 299 💬 |
271 |
Other: liquid meal test (mixed) |
- |
- |
- |
- |
299 [1] 299 💬 |
272 |
Other: liver evaluation |
- |
- |
- |
- |
240 [1] 240 💬 |
273 |
Other: liver questionnaire |
- |
- |
- |
- |
231 [1] 231 💬 |
274 |
Other: losartan |
Losartan |
[2] D00357 D00357, D08146 D08146 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
046 [1] 46 💬 |
275 |
Other: low blood pressure control |
- |
- |
- |
- |
067 [1] 67 💬 |
276 |
Other: low dose (1 mcg) acth stimulation test |
Corticotropin |
[1] D00146 D00146 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
193 [1] 193 💬 |
277 |
Other: low glycemic index meal |
- |
- |
- |
- |
299 [1] 299 💬 |
278 |
Other: low n-6 pufa diet |
- |
- |
- |
- |
096 [1] 96 💬 |
279 |
Other: low-intensity exercise therapy |
- |
- |
- |
- |
298 [1] 298 💬 |
280 |
Other: lower limb strength |
- |
- |
- |
- |
006 [1] 6 💬 |
281 |
Other: magnetic resonance imaging (mri) |
- |
- |
- |
- |
113 [1] 113 💬 |
282 |
Other: mangafodipir trisodium |
Mangafodipir |
[1] D08262 D08262 💬 |
- |
- |
058 [1] 58 💬 |
283 |
Other: meal challenge |
- |
- |
- |
- |
240 [1] 240 💬 |
284 |
Other: measure of endothelial function |
- |
- |
- |
- |
299 [1] 299 💬 |
285 |
Other: measurement of drug (adalimumab/infliximab) |
Adalimumab |
[2] D02597 D02597, D02598 D02598 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [2] 96, 97 💬 |
286 |
Other: medical air |
Medical air |
- |
- |
- |
085 [1] 85 💬 |
287 |
Other: medical chart review |
- |
- |
- |
- |
060 [1] 60 💬 |
288 |
Other: medical history questionnaires |
- |
- |
- |
- |
065 [1] 65 💬 |
289 |
Other: medication compliance phone call |
- |
- |
- |
- |
098 [1] 98 💬 |
290 |
Other: mesalazine |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
291 |
Other: metabolic exercise testing using stationary bicycle |
- |
- |
- |
- |
113 [1] 113 💬 |
292 |
Other: metformin |
Metformin |
[2] D00944 D00944, D04966 D04966 💬 |
PRKAA1 [2] PRKAA1, PRKAA2 💬 |
AMPK signaling pathway [19] AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
046 [1] 46 💬 |
293 |
Other: methacholine challenge test |
Methacholine |
- |
- |
- |
096 [1] 96 💬 |
294 |
Other: methotrexate therapy |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
295 |
Other: mibg label with i123 or i124 |
- |
- |
- |
- |
006 [1] 6 💬 |
296 |
Other: microindentation |
- |
- |
- |
- |
172 [1] 172 💬 |
297 |
Other: mitoxantrone - immunomodulator |
Mitoxantrone |
[2] D02166 D02166, D08224 D08224 💬 |
TOP2A [2] TOP2A, TOP2B 💬 |
Platinum drug resistance [1] Platinum drug resistance |
013 [1] 13 💬 |
298 |
Other: mixed meal test evaluation test arm |
- |
- |
- |
- |
299 [1] 299 💬 |
299 |
Other: mixed meal tolerance test |
- |
- |
- |
- |
299 [1] 299 💬 |
300 |
Other: mobile platform exercise |
- |
- |
- |
- |
006 [1] 6 💬 |
301 |
Other: mock injection |
- |
- |
- |
- |
090 [1] 90 💬 |
302 |
Other: modified atkins diet |
- |
- |
- |
- |
145 [1] 145 💬 |
303 |
Other: modified mixed meal tolerance test |
- |
- |
- |
- |
065 [1] 65 💬 |
304 |
Other: modified oral glucose tolerance test |
Dextrose, unspecified form |
- |
- |
- |
065 [1] 65 💬 |
305 |
Other: modified paleolithic diet |
- |
- |
- |
- |
013 [1] 13 💬 |
306 |
Other: monthly assessments of functional motor abilities by a trained therapist |
- |
- |
- |
- |
003 [1] 3 💬 |
307 |
Other: motor assessments before taking regular pd treatment |
- |
- |
- |
- |
006 [1] 6 💬 |
308 |
Other: motor assessments on regular pd treatment |
- |
- |
- |
- |
006 [1] 6 💬 |
309 |
Other: mp+ddci |
- |
- |
- |
- |
006 [1] 6 💬 |
310 |
Other: mp-equivalent |
- |
- |
- |
- |
006 [1] 6 💬 |
311 |
Other: mp-low |
- |
- |
- |
- |
006 [1] 6 💬 |
312 |
Other: mri |
- |
- |
- |
- |
006 [3] 6 , 127, 206 💬 |
313 |
Other: multidisciplinary intensive rehabilitation treatment |
- |
- |
- |
- |
006 [1] 6 💬 |
314 |
Other: muscle oxygenation |
- |
- |
- |
- |
299 [1] 299 💬 |
315 |
Other: music |
- |
- |
- |
- |
006 [1] 6 💬 |
316 |
Other: mybetaapp |
- |
- |
- |
- |
013 [1] 13 💬 |
317 |
Other: natalizumab |
Natalizumab |
[1] D06886 D06886 💬 |
ITGA4 [1] ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy [14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 [1] 13 💬 |
318 |
Other: natalizumab discontinuation |
Natalizumab |
[1] D06886 D06886 💬 |
ITGA4 [1] ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy [14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 [1] 13 💬 |
319 |
Other: natural herbs of coconut, aloe vera, and pepperint |
Aloe Vera Leaf |
- |
- |
- |
053 [1] 53 💬 |
320 |
Other: nbt-nm108 (0 g/day) |
- |
- |
- |
- |
013 [1] 13 💬 |
321 |
Other: neupro 4 mg / 24 hr. transdermal patch |
- |
- |
- |
- |
006 [1] 6 💬 |
322 |
Other: neurology exam |
- |
- |
- |
- |
019 [1] 19 💬 |
323 |
Other: neuromuscular evaluation |
- |
- |
- |
- |
013 [1] 13 💬 |
324 |
Other: nil per os |
- |
- |
- |
- |
291 [1] 291 💬 |
325 |
Other: nintendo wii fit balance exercises |
Isoxaflutole |
- |
- |
- |
013 [1] 13 💬 |
326 |
Other: no active treatment |
- |
- |
- |
- |
274 [1] 274 💬 |
327 |
Other: no anti-inflammatory treatment |
- |
- |
- |
- |
271 [1] 271 💬 |
328 |
Other: no device |
- |
- |
- |
- |
013 [1] 13 💬 |
329 |
Other: no doxycycline |
Doxycycline |
[5] D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
299 [1] 299 💬 |
330 |
Other: no enzyme therapy |
- |
- |
- |
- |
298 [1] 298 💬 |
331 |
Other: no intervention |
- |
- |
- |
- |
070 [1] 70 💬 |
332 |
Other: no intervention: standard of care |
- |
- |
- |
- |
085 [1] 85 💬 |
333 |
Other: no it treatment |
- |
- |
- |
- |
019 [1] 19 💬 |
334 |
Other: no msdmds therapy (control) |
- |
- |
- |
- |
013 [1] 13 💬 |
335 |
Other: no pancreatic enzyme replacement therapy |
- |
- |
- |
- |
299 [1] 299 💬 |
336 |
Other: no plasma exchange |
- |
- |
- |
- |
043 [2] 43, 44 💬 |
337 |
Other: no treatment |
- |
- |
- |
- |
053 [2] 53, 256 💬 |
338 |
Other: no treatment arm |
- |
- |
- |
- |
013 [1] 13 💬 |
339 |
Other: no treatment given |
- |
- |
- |
- |
078 [1] 78 💬 |
340 |
Other: non impact aerobics |
- |
- |
- |
- |
013 [1] 13 💬 |
341 |
Other: non-hormonal period |
- |
- |
- |
- |
299 [1] 299 💬 |
342 |
Other: non-motor symptoms |
- |
- |
- |
- |
006 [1] 6 💬 |
343 |
Other: noninvasive actigraphy monitor |
Methamidophos |
- |
- |
- |
086 [1] 86 💬 |
344 |
Other: nordic walking (only osteoporosis group) |
- |
- |
- |
- |
006 [1] 6 💬 |
345 |
Other: normal (control) diet |
- |
- |
- |
- |
240 [1] 240 💬 |
346 |
Other: normal diet |
- |
- |
- |
- |
096 [1] 96 💬 |
347 |
Other: normal saline |
- |
- |
- |
- |
013 [4] 13, 222, 226, 280 💬 |
348 |
Other: normal saline for injection |
- |
- |
- |
- |
084 [1] 84 💬 |
349 |
Other: ns |
- |
- |
- |
- |
096 [1] 96 💬 |
350 |
Other: numerical rating scale |
- |
- |
- |
- |
046 [1] 46 💬 |
351 |
Other: nutrition counseling |
- |
- |
- |
- |
298 [1] 298 💬 |
352 |
Other: obese |
- |
- |
- |
- |
075 [1] 75 💬 |
353 |
Other: observation |
- |
- |
- |
- |
265 [1] 265 💬 |
354 |
Other: observation of ocrelizumab as treatment in rrms patients |
Ocrelizumab |
[1] D05218 D05218 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [1] 13 💬 |
355 |
Other: observation only |
- |
- |
- |
- |
331 [1] 331 💬 |
356 |
Other: observational |
- |
- |
- |
- |
090 [1] 90 💬 |
357 |
Other: observational cohort |
- |
- |
- |
- |
006 [1] 6 💬 |
358 |
Other: observational control |
- |
- |
- |
- |
013 [1] 13 💬 |
359 |
Other: ogtt |
- |
- |
- |
- |
299 [1] 299 💬 |
360 |
Other: on-demand treatment |
- |
- |
- |
- |
299 [1] 299 💬 |
361 |
Other: one-leg stance test |
- |
- |
- |
- |
013 [1] 13 💬 |
362 |
Other: ophthalmologic examinations |
- |
- |
- |
- |
299 [1] 299 💬 |
363 |
Other: optimized supportive care |
- |
- |
- |
- |
066 [1] 66 💬 |
364 |
Other: optimizing basal infusion (b.i) |
- |
- |
- |
- |
070 [1] 70 💬 |
365 |
Other: optional blood-oxygen-level dependent functionalmri |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
006 [1] 6 💬 |
366 |
Other: oral glucose tolerance test |
Dextrose, unspecified form |
- |
- |
- |
160 [3] 160, 195, 299 💬 |
367 |
Other: oral glucose tolerance test (ogtt) assessment arm |
Dextrose, unspecified form |
- |
- |
- |
299 [1] 299 💬 |
368 |
Other: oral nitric oxide testing |
Nitric Oxide |
[1] D00074 D00074 💬 |
- |
- |
098 [1] 98 💬 |
369 |
Other: other biologic agents |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
370 |
Other: other intervention(s) |
- |
- |
- |
- |
070 [1] 70 💬 |
371 |
Other: other: disease modifying therapies (dmt) |
- |
- |
- |
- |
013 [1] 13 💬 |
372 |
Other: other: symptomatic treatment of als |
- |
- |
- |
- |
002 [1] 2 💬 |
373 |
Other: outpatient rheumatology department |
- |
- |
- |
- |
046 [1] 46 💬 |
374 |
Other: overnight metyrapone test |
Metyrapone |
[2] D00410 D00410, D05019 D05019 💬 |
CYP11B1 [1] CYP11B1 💬 |
Cortisol synthesis and secretion [4] Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis |
193 [1] 193 💬 |
375 |
Other: oxygen |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
085 [1] 85 💬 |
376 |
Other: oxygen (2liter/min) |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
085 [1] 85 💬 |
377 |
Other: oxygen (4liter/min) |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
085 [1] 85 💬 |
378 |
Other: oxygen - air |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
299 [1] 299 💬 |
379 |
Other: oxygen supplementation |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
086 [1] 86 💬 |
380 |
Other: packing |
- |
- |
- |
- |
227 [1] 227 💬 |
381 |
Other: pain |
- |
- |
- |
- |
013 [1] 13 💬 |
382 |
Other: palliative care |
- |
- |
- |
- |
019 [5] 19, 65, 120, 160, 326 💬 |
383 |
Other: parkinson mpower mobile application |
- |
- |
- |
- |
006 [1] 6 💬 |
384 |
Other: passive : lecture series |
- |
- |
- |
- |
013 [1] 13 💬 |
385 |
Other: pcdai |
- |
- |
- |
- |
096 [1] 96 💬 |
386 |
Other: pd exercise intervention |
- |
- |
- |
- |
006 [1] 6 💬 |
387 |
Other: pd vitamin + exercise |
- |
- |
- |
- |
006 [1] 6 💬 |
388 |
Other: peak |
- |
- |
- |
- |
013 [1] 13 💬 |
389 |
Other: peanut butter |
Peanut |
- |
- |
- |
013 [1] 13 💬 |
390 |
Other: pentadecanoic acid (pa) and triheptadecanoin (tha) |
- |
- |
- |
- |
299 [1] 299 💬 |
391 |
Other: pentasa (mesalamine/ 5-aminosalicylic acid (5-asa) |
Aminosalicylic acid |
[2] D00162 D00162, D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
392 |
Other: periodized exercise training |
- |
- |
- |
- |
013 [1] 13 💬 |
393 |
Other: pharmacogenomic study |
- |
- |
- |
- |
026 [1] 26 💬 |
394 |
Other: pharmacokinetic analysis |
- |
- |
- |
- |
049 [1] 49 💬 |
395 |
Other: pharmacological study |
- |
- |
- |
- |
028 [7] 28, 34, 62, 74, 89, 232, 331 💬 |
396 |
Other: phenylalanine (phe)-restricted diet |
Phenylalanine |
[1] D00021 D00021 💬 |
- |
- |
240 [1] 240 💬 |
397 |
Other: physalis angulata ethanol extract |
Ethanol |
[4] D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
051 [1] 51 💬 |
398 |
Other: physical function performance test |
- |
- |
- |
- |
006 [1] 6 💬 |
399 |
Other: physical therapy |
- |
- |
- |
- |
006 [2] 6 , 70 💬 |
400 |
Other: pittsburgh compound b [11c]-pib |
Pittsburgh Compound B |
- |
- |
- |
006 [1] 6 💬 |
401 |
Other: plant-based diet |
- |
- |
- |
- |
046 [1] 46 💬 |
402 |
Other: plasticity-based computerized cognitive remediation program |
- |
- |
- |
- |
013 [1] 13 💬 |
403 |
Other: pnf |
- |
- |
- |
- |
013 [1] 13 💬 |
404 |
Other: position sense |
- |
- |
- |
- |
013 [1] 13 💬 |
405 |
Other: postoperative nausea and vomiting at 24 hour |
- |
- |
- |
- |
235 [1] 235 💬 |
406 |
Other: postoperative nausea and vomiting at 6 hour |
- |
- |
- |
- |
235 [1] 235 💬 |
407 |
Other: postoperative pain at 24 hour |
- |
- |
- |
- |
235 [1] 235 💬 |
408 |
Other: postoperative pain at 6 hour |
- |
- |
- |
- |
235 [1] 235 💬 |
409 |
Other: postoperative sore throat and hoarseness at 24 hour |
- |
- |
- |
- |
235 [1] 235 💬 |
410 |
Other: postoperative sore throat and hoarseness at 6 hour |
- |
- |
- |
- |
235 [1] 235 💬 |
411 |
Other: potable water |
Water |
[1] D00001 D00001 💬 |
- |
- |
019 [1] 19 💬 |
412 |
Other: prednisone |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
413 |
Other: pretreatment antibiotics |
- |
- |
- |
- |
097 [1] 97 💬 |
414 |
Other: progressive exercise |
- |
- |
- |
- |
013 [1] 13 💬 |
415 |
Other: propensity score |
- |
- |
- |
- |
013 [1] 13 💬 |
416 |
Other: prospective observational registry |
- |
- |
- |
- |
003 [1] 3 💬 |
417 |
Other: psp |
- |
- |
- |
- |
013 [1] 13 💬 |
418 |
Other: pth based calcium carbonate and calcitriol repletion |
Calcitriol |
[3] D00129 D00129, D00932 D00932, D10802 D10802 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
235 [1] 235 💬 |
419 |
Other: pulmonary function testing (pft) |
- |
- |
- |
- |
113 [1] 113 💬 |
420 |
Other: pulmonary rehabilitation program |
- |
- |
- |
- |
085 [1] 85 💬 |
421 |
Other: qalcimum questionnaire |
- |
- |
- |
- |
013 [2] 13, 46 💬 |
422 |
Other: quality of life assessment |
- |
- |
- |
- |
122 [1] 122 💬 |
423 |
Other: quality of life questionnaire |
- |
- |
- |
- |
019 [1] 19 💬 |
424 |
Other: quality-of-life assessment |
- |
- |
- |
- |
034 [5] 34, 36, 51, 96, 298 💬 |
425 |
Other: quercetin |
Quercetin |
- |
- |
- |
299 [1] 299 💬 |
426 |
Other: questionnaire administration |
- |
- |
- |
- |
016 [4] 16, 34, 51, 298 💬 |
427 |
Other: questionnaires |
- |
- |
- |
- |
006 [5] 6 , 13, 41, 93, 96 💬 |
428 |
Other: reaction time and postural control |
- |
- |
- |
- |
299 [1] 299 💬 |
429 |
Other: real-time data capture app |
Bifenthrin |
- |
- |
- |
046 [1] 46 💬 |
430 |
Other: recommendation with regard to nutrition |
- |
- |
- |
- |
006 [1] 6 💬 |
431 |
Other: reduction group 1 |
- |
- |
- |
- |
046 [1] 46 💬 |
432 |
Other: reduction group 2 |
- |
- |
- |
- |
046 [1] 46 💬 |
433 |
Other: refered to general practice |
- |
- |
- |
- |
046 [1] 46 💬 |
434 |
Other: resistance exercise program |
- |
- |
- |
- |
046 [1] 46 💬 |
435 |
Other: review of past medical history, clinical exam, and electroencephalogram, polysomnography and urine samples of melatonin and pupillometry. |
Melatonin |
[1] D08170 D08170 💬 |
MTNR1A [2] MTNR1A, MTNR1B 💬 |
Circadian entrainment [2] Circadian entrainment, Neuroactive ligand-receptor interaction |
149 [1] 149 💬 |
436 |
Other: rhythmic auditory stimulation (ras) |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
437 |
Other: rhythmic balance-movement training (rbmt) |
Isoxaflutole |
- |
- |
- |
006 [1] 6 💬 |
438 |
Other: rmst |
- |
- |
- |
- |
256 [1] 256 💬 |
439 |
Other: rosemary essential oil |
Rosemary |
- |
- |
- |
051 [1] 51 💬 |
440 |
Other: rotigotine |
Rotigotine |
[1] D05768 D05768 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
441 |
Other: routine |
- |
- |
- |
- |
240 [1] 240 💬 |
442 |
Other: routine management |
- |
- |
- |
- |
291 [1] 291 💬 |
443 |
Other: routine therapy |
- |
- |
- |
- |
299 [1] 299 💬 |
444 |
Other: rp% measurement by fcm as a diagnostic test for itp |
- |
- |
- |
- |
063 [1] 63 💬 |
445 |
Other: salbutamol nebulisation and with cpap |
Salbutamol |
[1] D02147 D02147 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
228 [1] 228 💬 |
446 |
Other: saline |
- |
- |
- |
- |
002 [8] 2 , 6 , 46, 97, 98, 256, 274, 301 💬 |
447 |
Other: saline as a nasal spray |
- |
- |
- |
- |
226 [1] 226 💬 |
448 |
Other: saline solution |
- |
- |
- |
- |
067 [1] 67 💬 |
449 |
Other: saline solution. |
- |
- |
- |
- |
067 [1] 67 💬 |
450 |
Other: screening to prevent falls |
- |
- |
- |
- |
006 [1] 6 💬 |
451 |
Other: serum calcium concentrations results |
Calcium |
- |
- |
- |
235 [1] 235 💬 |
452 |
Other: serum levels of angiogenin, bfgf, vegf |
Basic Fibroblast Growth Factor |
- |
- |
- |
056 [1] 56 💬 |
453 |
Other: sham |
- |
- |
- |
- |
019 [2] 19, 301 💬 |
454 |
Other: sham (no implant) |
- |
- |
- |
- |
090 [1] 90 💬 |
455 |
Other: sham abdominal compression |
- |
- |
- |
- |
017 [1] 17 💬 |
456 |
Other: sham comparator |
- |
- |
- |
- |
299 [1] 299 💬 |
457 |
Other: sham group |
- |
- |
- |
- |
006 [1] 6 💬 |
458 |
Other: sham procedure |
- |
- |
- |
- |
090 [1] 90 💬 |
459 |
Other: sham surgery |
- |
- |
- |
- |
006 [1] 6 💬 |
460 |
Other: sham-procedure (dose cohort 1&2 only) |
- |
- |
- |
- |
090 [2] 90, 303 💬 |
461 |
Other: simvastatin |
Simvastatin |
[1] D00434 D00434 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
046 [1] 46 💬 |
462 |
Other: sle treatment |
- |
- |
- |
- |
049 [1] 49 💬 |
463 |
Other: smartphone application |
- |
- |
- |
- |
049 [1] 49 💬 |
464 |
Other: smartphone-based balance exercises |
Isoxaflutole |
- |
- |
- |
006 [1] 6 💬 |
465 |
Other: sodium chloride |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
051 [1] 51 💬 |
466 |
Other: specific sl-therapy |
- |
- |
- |
- |
006 [1] 6 💬 |
467 |
Other: specifically design 6 month resistance training program |
- |
- |
- |
- |
013 [1] 13 💬 |
468 |
Other: spinning grp |
- |
- |
- |
- |
013 [1] 13 💬 |
469 |
Other: sputum sample |
- |
- |
- |
- |
299 [1] 299 💬 |
470 |
Other: standard |
- |
- |
- |
- |
067 [1] 67 💬 |
471 |
Other: standard blood pressure control |
- |
- |
- |
- |
067 [1] 67 💬 |
472 |
Other: standard care |
- |
- |
- |
- |
227 [1] 227 💬 |
473 |
Other: standard immune suppression, oral |
- |
- |
- |
- |
228 [1] 228 💬 |
474 |
Other: standard nutrition |
- |
- |
- |
- |
096 [1] 96 💬 |
475 |
Other: standard of care |
- |
- |
- |
- |
013 [7] 13, 49, 64, 85, 96, 245, 246 💬 |
476 |
Other: standard of care (soc) |
- |
- |
- |
- |
062 [1] 62 💬 |
477 |
Other: standard of care sildenafil |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
090 [2] 90, 301 💬 |
478 |
Other: standard steroid treatment |
- |
- |
- |
- |
113 [1] 113 💬 |
479 |
Other: standard therapy |
- |
- |
- |
- |
049 [1] 49 💬 |
480 |
Other: standard treatment |
- |
- |
- |
- |
227 [1] 227 💬 |
481 |
Other: standard treatment according to the clinical protocols |
- |
- |
- |
- |
049 [1] 49 💬 |
482 |
Other: standard-of-care |
- |
- |
- |
- |
086 [1] 86 💬 |
483 |
Other: standardized meals |
- |
- |
- |
- |
086 [1] 86 💬 |
484 |
Other: standardized scales: mds-updrs (part ii to iv) and rdrs |
- |
- |
- |
- |
006 [1] 6 💬 |
485 |
Other: static balance test |
Isoxaflutole |
- |
- |
- |
013 [1] 13 💬 |
486 |
Other: stem cell transplant |
- |
- |
- |
- |
096 [1] 96 💬 |
487 |
Other: sterile normal saline (0.9% nacl) |
- |
- |
- |
- |
231 [1] 231 💬 |
488 |
Other: sterile saline |
- |
- |
- |
- |
046 [1] 46 💬 |
489 |
Other: stool sample |
- |
- |
- |
- |
006 [2] 6 , 299 💬 |
490 |
Other: strength training |
- |
- |
- |
- |
013 [1] 13 💬 |
491 |
Other: subacute hypoxic exposures |
- |
- |
- |
- |
086 [1] 86 💬 |
492 |
Other: subconjunctival injection of saline |
- |
- |
- |
- |
090 [1] 90 💬 |
493 |
Other: sugar pill |
- |
- |
- |
- |
090 [1] 90 💬 |
494 |
Other: sulfur pool & medicinal mud |
- |
- |
- |
- |
046 [1] 46 💬 |
495 |
Other: supervised physical therapy |
- |
- |
- |
- |
013 [1] 13 💬 |
496 |
Other: surgery |
- |
- |
- |
- |
074 [2] 74, 96 💬 |
497 |
Other: swallowing quality of life questionnaire |
- |
- |
- |
- |
002 [1] 2 💬 |
498 |
Other: swallowing related quality of life questionnaire |
- |
- |
- |
- |
002 [1] 2 💬 |
499 |
Other: symptom survey |
- |
- |
- |
- |
098 [1] 98 💬 |
500 |
Other: symptomatic hypocalcaemia at 24 hour |
- |
- |
- |
- |
235 [1] 235 💬 |
501 |
Other: symptomatic hypocalcaemia at 6 hour |
- |
- |
- |
- |
235 [1] 235 💬 |
502 |
Other: t-dcs group |
- |
- |
- |
- |
006 [1] 6 💬 |
503 |
Other: tampa kinesiophobia scale, berg-balance test, international physical activity questionnaire-short form, falls efficacy scale |
Isoxaflutole |
- |
- |
- |
006 [1] 6 💬 |
504 |
Other: technetium [tc-99m] sulfur colloid and indium [in-111] dtpa |
Indium |
[1] D05422 D05422 💬 |
- |
- |
299 [1] 299 💬 |
505 |
Other: test soda |
- |
- |
- |
- |
299 [1] 299 💬 |
506 |
Other: the center for neurologic studies bulbar function scale |
- |
- |
- |
- |
002 [1] 2 💬 |
507 |
Other: the center for neurologic study bulbar function scale |
- |
- |
- |
- |
002 [1] 2 💬 |
508 |
Other: the patients' parents have to complete the vineland ii adaptive behavior scales scoring, the sleep disturbance scale for children (sdsc) and horne & ostberg circadian typology questionnaire |
- |
- |
- |
- |
149 [1] 149 💬 |
509 |
Other: the timed 360° turn test |
- |
- |
- |
- |
006 [1] 6 💬 |
510 |
Other: therapy education |
- |
- |
- |
- |
097 [1] 97 💬 |
511 |
Other: threonine |
Threonine |
[1] D00041 D00041 💬 |
- |
- |
096 [2] 96, 97 💬 |
512 |
Other: timed up an go test |
- |
- |
- |
- |
013 [1] 13 💬 |
513 |
Other: timed up and go test |
- |
- |
- |
- |
006 [1] 6 💬 |
514 |
Other: tobacco questionnaire |
Tobacco leaf |
- |
- |
- |
299 [1] 299 💬 |
515 |
Other: tobramycin time of administration |
Tobramycin |
[2] D00063 D00063, D02542 D02542 💬 |
- |
- |
299 [1] 299 💬 |
516 |
Other: training groupe |
- |
- |
- |
- |
013 [1] 13 💬 |
517 |
Other: transthoracic echocardiography at rest, during plr, hg and cpx (including blood gas analysis in both groups). additionally fallot patients will undergo routine blood testings. |
- |
- |
- |
- |
215 [1] 215 💬 |
518 |
Other: triangular test |
- |
- |
- |
- |
096 [1] 96 💬 |
519 |
Other: trunk impairment |
- |
- |
- |
- |
013 [1] 13 💬 |
520 |
Other: trunk impairment scale |
- |
- |
- |
- |
006 [1] 6 💬 |
521 |
Other: trunk position sense |
- |
- |
- |
- |
013 [1] 13 💬 |
522 |
Other: tyramine |
Tyramine |
- |
- |
- |
006 [1] 6 💬 |
523 |
Other: uc-mscs by peripheral intravenous infusion |
Human Umbilical Cord Mesenchymal Stem Cells |
- |
- |
- |
096 [1] 96 💬 |
524 |
Other: ulcerative colitis diet |
- |
- |
- |
- |
097 [1] 97 💬 |
525 |
Other: ultrasonography assessment |
- |
- |
- |
- |
049 [1] 49 💬 |
526 |
Other: unified parkinson's disease rating scale |
- |
- |
- |
- |
006 [1] 6 💬 |
527 |
Other: untreated cohort |
- |
- |
- |
- |
085 [1] 85 💬 |
528 |
Other: use of a postpartum diary and additional blood draws |
- |
- |
- |
- |
288 [1] 288 💬 |
529 |
Other: use of a postpartum diary and additional blood draws. |
- |
- |
- |
- |
288 [1] 288 💬 |
530 |
Other: uspio mri - gadolinium mri |
Gadolinium |
- |
- |
- |
013 [1] 13 💬 |
531 |
Other: usual care |
- |
- |
- |
- |
046 [1] 46 💬 |
532 |
Other: usual care arm exercise |
- |
- |
- |
- |
006 [1] 6 💬 |
533 |
Other: usual drug treatment of parkinson's disease |
- |
- |
- |
- |
006 [1] 6 💬 |
534 |
Other: vasculopathy assessment |
- |
- |
- |
- |
051 [1] 51 💬 |
535 |
Other: vegan diet |
- |
- |
- |
- |
046 [1] 46 💬 |
536 |
Other: vegetable oil |
- |
- |
- |
- |
257 [1] 257 💬 |
537 |
Other: vehicle |
- |
- |
- |
- |
160 [1] 160 💬 |
538 |
Other: vehicle (d5w or saline) |
- |
- |
- |
- |
066 [1] 66 💬 |
539 |
Other: vestibular habituation exercises |
- |
- |
- |
- |
013 [1] 13 💬 |
540 |
Other: vestibular rehabilitation: balance and eye movement exercises |
Isoxaflutole |
- |
- |
- |
013 [1] 13 💬 |
541 |
Other: virtual reality group |
- |
- |
- |
- |
013 [1] 13 💬 |
542 |
Other: visual acuity (va) |
- |
- |
- |
- |
090 [2] 90, 301 💬 |
543 |
Other: vital signs |
- |
- |
- |
- |
019 [1] 19 💬 |
544 |
Other: vitamin k |
Phylloquinone |
[1] D00148 D00148 💬 |
- |
- |
013 [1] 13 💬 |
545 |
Other: vitamin k cream |
Phylloquinone |
[1] D00148 D00148 💬 |
- |
- |
013 [1] 13 💬 |
546 |
Other: voluntary cough test |
- |
- |
- |
- |
006 [1] 6 💬 |
547 |
Other: walk distance test |
- |
- |
- |
- |
058 [1] 58 💬 |
548 |
Other: water |
Water |
[1] D00001 D00001 💬 |
- |
- |
067 [1] 67 💬 |
549 |
Other: water prescription |
Water |
[1] D00001 D00001 💬 |
- |
- |
067 [1] 67 💬 |
550 |
Other: wheat flour |
Wheat |
[1] D06902 D06902 💬 |
- |
- |
266 [1] 266 💬 |
551 |
Other: withdrawal from alpha1 antitrypsin replacement therapy |
- |
- |
- |
- |
231 [1] 231 💬 |
552 |
Other: withdrawal of dalfampridine-er 10mg |
Dalfampridine |
[1] D04127 D04127 💬 |
KCNA4 [4] KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion [4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 [1] 13 💬 |
553 |
Other: xanthan gum |
Xanthan gum |
[1] D06333 D06333 💬 |
- |
- |
098 [1] 98 💬 |